Gomisin E attenuates pentobarbital-induced sleep deficits in aging-related insomnia: an <i>in vivo</i> and <i>in silico</i> study implicating cholinergic signaling.

Overview

1. Department of Neurology, The First Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, Hunan, China
2. Department of Nephrology, The Third Affiliated Hospital of Southern Medical University, Guangzhou, Guangdong, China

Abstract

Objective: To investigate the therapeutic effects of gomisin E on insomnia in aged rats and to elucidate the underlying mechanisms.

Methods: An aging-related insomnia rat model was established by intraperitoneal injection of D-galactose combined with p-chlorophenylalanine (PCPA). Rats were treated with gomisin E at different doses (5, 15, and 45 mg/kg). Sleep quality, depressive-like behaviors, and cognitive function were evaluated using the pentobarbital sodium-induced sleep test, sucrose preference test, and Morris water maze test, respectively. Potential targets and signaling pathways were screened using bioinformatics analysis. The contents of acetylcholine (ACh) and choline acetyltransferase (ChAT) and acetylcholinesterase (AChE) activities in the hippocampus and ileum were determined using commercial assay kits. Protein levels of muscarinic acetylcholine receptor M1 and M2 (CHRM1 and CHRM2) in the hippocampus were detected by Western blot analysis.

Results: Gomisin E dose-dependently alleviated body weight loss, sleep disorders, depressive-like behaviors, and cognitive dysfunction in aged rats with insomnia, significantly reducing pro-inflammatory cytokine levels. The potential mechanisms of gomisin E involved circadian rhythm regulation, inflammatory responses, the C-type lectin receptor signaling pathway, and cholinergic synapses. Gomisin E increased ACh content and ChAT activity, decreased AChE activity in the hippocampus and ileum, and upregulated the protein expression of CHRM1 and CHRM2 in the hippocampus.

Conclusion: Gomisin E effectively ameliorates D-galactose/PCPA-induced insomnia and the associated depressive-like behaviors and cognitive dysfunction. The underlying mechanisms may involve suppression of systemic inflammation and restoration of cholinergic system homeostasis.

Reproduced under the paper's license (CC BY), from the paper cited above.

Code

The paper links to its data, not to its authors' code: see the Data section.

Tracing map

A tracing map links a paper to the code its authors published: this paper has none, so it has no map.

Data

Datasets cited

• geo:GSE208668, at NCBI GEO; found in the text, “Identification of gomisin E and…”

Data availability statement

The original contributions presented in the study are included in the article/supplementary material, further inquiries can be directed to the corresponding author.

Reproduced under the paper's license (CC BY), from the paper cited above.

Versions

The history of this record: each version stored by the harvester or made by a correction of its authors or of the maintainers of its code, and what changed in its facts. The texts of the paper (its abstract, its availability statements) are not part of it; versions that changed only those are not listed.

Version 1, 28 September 2026: the first record

Recorded: type, language, journal, volume, pages, dates, 3 authors, 5 keywords, 39 references.

Cite

This paper

Yang, F., Jiang, F., & Li, X. (2026). Gomisin E attenuates pentobarbital-induced sleep deficits in aging-related insomnia: an <i>in vivo</i> and <i>in silico</i> study implicating cholinergic signaling. Frontiers in psychology, 17, 1821889. https://doi.org/10.3389/fpsyg.2026.1821889

Similar papers

The papers with a page that share the most with this one: the tools found in their code, their categories, datasets, cited references and authors, the rarest counting most.

[1] doi:10.2147/nss.s582222

Network Pharmacology-Based Elucidation of Gu's Anshen Decoction in Modulating TNF Signaling to Ameliorate Insomnia.

Journal: Nature and science of sleep

In common: NCBI GEO GSE208668, sleep disorders, rat, cellular / molecular, 1 reference

[2] doi:10.1186/s12916-026-04787-y

A human-derived Bacteroides strain attenuates depressive-like behavior in a rat model of social defeat-induced stress.

Journal: BMC medicine

In common: depression, rat, 1 reference

[3] doi:10.3389/fmicb.2026.1850738

Correlation study of polysomnographic parameters, serological markers, and gut microbiota in patients with short-sleep insomnia: a real-world study.

Journal: Frontiers in microbiology

In common: sleep disorders, 1 reference

[4] doi:10.7717/peerj.21426 [code]

Integrated transcriptomic identification and validation reveal key autophagy-associated biomarkers in sleep deprivation.

Journal: PeerJ

In common: sleep disorders, rat, cellular / molecular

[5] doi:10.1111/acel.70544

Multi-Omics Reveals Dysregulated Neurotransmitter Systems in Aging and CNS Disorders.

Journal: Aging cell

In common: cellular / molecular, 1 reference

[6] doi:10.1093/braincomms/fcag316 [code]

Structural, functional and neurochemical imaging mapping of non-motor symptoms in Parkinson's disease.

Journal: Brain communications

In common: sleep disorders, depression

[7] doi:10.64898/2026.05.08.26348885 [code]

Insights from nine nights of self-applied, low-density sleep EEG during sleep restriction therapy: a proof-of-concept evaluation

Journal: medRxiv (preprint)

In common: sleep disorders, depression

[8] doi:10.1007/s11033-026-12462-x

METTL3-dependent m⁶A maturation of miR-140-3p contributes to hippocampal neuronal apoptosis through the OTX2/Wnt/β-catenin axis under chronic stress.

Journal: Molecular biology reports

In common: depression, rat, cellular / molecular

[9] doi:10.1111/jnc.70502 [code]

The Converging Effects of Different Categories of Antidepressants on the Brain: A Systematic Meta-Analysis of Public Transcriptional Profiling Data From the Hippocampus and Cortex.

Journal: Journal of neurochemistry

In common: depression, rat, cellular / molecular

[10] doi:10.3390/ph19050751

Cang-Ai Volatile Oil Ameliorates Chronic Unpredictable Mild Stress-Induced Depression-like Symptoms in Rats by Regulating NT/Trk Signaling Pathway.

Journal: Pharmaceuticals (Basel, Switzerland)

In common: depression, rat, cellular / molecular

Contribute

The authors of this paper can claim it, correct its record and validate its tracing map, and the maintainers of its code (its owner, or a public member of its organization) correct what it says of their repository; anyone signed in can ask for its removal. Every request goes to OSCR's own machine, which answers it; your account page follows them.

Request its removal

To ask OSCR to remove this record, the copies of its authors' scripts or its tracing map, use the removal request page: signed in, you say who you are, what to remove and why, then review and confirm the request. Published rules decide every request (how).

Discussion: questions and error reports about this paper and its code, from signed-in readers and its authors. It opens with sign-in.

Reproductions: reports from readers who ran the authors' code: what they reproduced, with which environment, commit and data. It opens with sign-in.

Activity: what happens around this paper: new versions of its record, its map's validation, discussions and reproductions. It opens with sign-in.